{
    "2020-04-10": [
        [
            {
                "time": "2020-05-13",
                "original_text": "Drugmaker Eli Lilly starts clinical testing of therapies for COVID-19",
                "features": {
                    "keywords": [
                        "clinical testing",
                        "therapies",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-13",
                "original_text": "Eli Lilly to study use of arthritis drug to treat COVID-19",
                "features": {
                    "keywords": [
                        "arthritis drug",
                        "treat",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-13",
                "original_text": "Lilly Begins Clinical Testing of Therapies for COVID-19",
                "features": {
                    "keywords": [
                        "Begins",
                        "Clinical Testing",
                        "Therapies",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}